Table 2.
Estimated malaria cases averted
| Country | Total cases averted in thousands | Children using an ITN | Children not using an ITN | ||
|---|---|---|---|---|---|
| Cases averted in thousands (uncertainty range) | Percentage of total averted across all countries | Cases averted in thousands (uncertainty range) | Percentage of total averted across all countries | ||
| Angola | 162 (143–180) | 54 (47–60) | 0 | 109 (96–121) | 1 |
| Benin | 282 (248–313) | 220 (193–244) | 1 | 63 (55–69) | 0 |
| Burkina Faso | 1326 (1167–1473) | 729 (641–809) | 4 | 597 (525–663) | 3 |
| Burundi | 583 (513–647) | 237 (208–263) | 1 | 346 (305–385) | 2 |
| Cameroon | 1359 (1195–1508) | 219 (193–243) | 1 | 1140 (1002–1265) | 6 |
| Democratic Republic of Congo | 2307 (2029–2562) | 1420 (1249–1576) | 7 | 888 (781–985) | 4 |
| Côte d’Ivoire | 834 (733–926) | 433 (381–481) | 2 | 400 (352–445) | 2 |
| Ghana | 836 (736–929) | 465 (409–516) | 2 | 371 (327–412) | 2 |
| Guinea | 396 (348–439) | 160 (140–177) | 1 | 236 (208–262) | 1 |
| Kenya | 536 (471–595) | 399 (351–443) | 2 | 137 (120–152) | 1 |
| Liberia | 222 (195–246) | 94 (82–104) | 0 | 128 (113–142) | 1 |
| Malawi | 930 (818–1033) | 416 (366–462) | 2 | 514 (452–571) | 3 |
| Mali | 575 (506–638) | 465 (409–516) | 2 | 110 (97–123) | 1 |
| Mozambique | 1251 (1100–1389) | 692 (608–768) | 3 | 559 (492–621) | 3 |
| Nigeria | 5684 (4999–6311) | 2887 (2539–3205) | 14 | 2797 (2460–3106) | 14 |
| Sierra Leone | 351 (309–390) | 204 (180–227) | 1 | 147 (129–163) | 1 |
| Tanzania | 522 (459–580) | 338 (297–376) | 2 | 184 (162–204) | 1 |
| Togo | 578 (508–641) | 264 (232–293) | 1 | 314 (276–348) | 2 |
| Uganda | 1317 (1158–1462) | 889 (782–987) | 4 | 428 (377–476) | 2 |
| Zambia | 491 (432–545) | 245 (215–272) | 1 | 246 (217–273) | 1 |
| Total | 20,542 (18,066–22,807) | 10,827 (9522–12,021) | 53 | 9715 (8544–10,786) | 47 |
The numbers of cases, and percentage relative to the total across all countries, that could be averted annually in 12–59-month-old children if universal coverage of the RTS,S/AS01 vaccine was achieved, for those who received the DTP3 vaccine in each country, assuming that all children who received the DTP3 vaccine also received all four doses of the RTS,S malaria vaccine. These estimates are calculated for individual admin-1 units and aggregated at the country level. Uncertainty ranges in parentheses represent the calculated impact based on the 95% vaccine efficacy confidence interval reported in the clinical trial [18]